Cardinal Health, Inc.
CAH Healthcare · Medical DistributionFairly valued.
Fairly Valued (Neutral) — Filing.fyi's reading derived from the latest 10-K and forensic scores.
What the filing actually says.
Cardinal Health’s Q3 Fiscal 2026 Form 10-Q, filed April 30, 2026, presents an MD&A that begins with a procedural overview. The discussion explicitly states its concern with “material changes in financial condition and results of operations,” focusing on cash flows between the specified periods. This framing sets the stage for a document that intends to update rather than re-establish the company’s entire financial narrative, immediately directing the reader to seek additional context.
The forensic accounting scores for this filing are notably absent, precluding a quantitative assessment of potential red flags or fundamental strength. Beneish’s 1999 eight-ratio earnings-manipulation detector (M-Score), Altman’s Z″ — a 1968 bankruptcy-distress index, and Piotroski’s F-Score, a 9-point fundamental strength scan, are all listed as “not available.” Similarly, the Fog Index — readability score (12 = newspaper, 18+ = obfuscatory) — is also unavailable, meaning the filing’s textual clarity cannot be objectively measured here.
The MD&A’s introductory language, specifically the instruction that the “discussion and analysis in this Form 10-Q should be read in conjunction with the MD&A included in our 2025 Form 10-K,” is a key observation. This directive signals that the current quarterly report is not designed as a standalone document for comprehensive analysis. It implies that a full understanding of Cardinal Health’s financial position and operational results requires consulting prior, more detailed annual disclosures, rather than relying solely on the condensed information provided in the 10-Q.
This reading, constrained by the provided excerpts and the absence of forensic scores, offers limited insight into the security’s underlying value or potential mispricing. The filing’s introductory remarks clarify its scope as an update to prior disclosures, rather than a complete financial narrative. Without specific financial figures, risk factors, or quantitative forensic metrics, the document primarily informs readers about the company’s reporting approach and the necessary context for its quarterly statements.
Filing timeline
- Apr 30, 20268-KMaterial event (2026-04-30)No specific items found in 8-K.0Read →
- Apr 30, 202610-QQuarterly report (2026-03-31)Period: 2026-03-310Read →
- Mar 23, 20268-KMaterial event (2026-03-17)### Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 0Read →
- Mar 5, 20268-KMaterial event (2026-03-02)### Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 0Read →
- Sep 16, 2025DEF 14AProxy statement (2025-11-05)0Read →
- Aug 12, 202510-KAnnual report (2025-06-30)Period: 2025-06-300Read →
If this case caught your eye
Financial Shenanigans
Schilit's framework for the seven shenanigan types is the standard reference for the kind of MD&A pattern-matching this site does.
View on Amazon →The Interpretation of Financial Statements
The original — and still the clearest — explanation of why working-capital trends matter more than headline earnings.
View on Amazon →Quality of Earnings
Out of print, expensive, worth it. The chapter on receivables-vs-revenue divergence applies almost word-for-word to most distressed filings.
View on Amazon →